We are pleased by the Senate’s confirmation today of Dr. Monica Bertagnolli as Director of the National Institutes of Health (NIH), and we are excited at the prospect of continuing to collaborate with our friend and colleague in her new role. Dr. Bertagnolli is well known for her commitment to the entire research continuum from basic to clinical science and her focus on improving outcomes for patients. Her appointment will facilitate and support key objectives advancing medical research across the spectrum. Congratulations Dr. Bertagnolli! We’re confident in our shared values as they pertain to the advancement of medical research and look forward to the continued collaboration between the ECOG-ACRIN Cancer Research Group and NIH.
Peter J. O’Dwyer, MD and Mitchell D. Schnall, MD, PhD